Key Developments in Cannabis and Psychedelics Policy
Recent weeks have seen a flurry of activity across federal, state, and international arenas, reflecting shifting attitudes toward cannabis, medical marijuana, and psychedelic therapies. Below is a detailed roundup of the most notable actions, backed by publicly available records and reporting from Marijuana Moment.
Federal Actions
The House of Representatives advanced two amendments that could reshape veterans’ access to medical cannabis and broaden awareness of psychedelic treatments. One amendment permits Department of Veterans Affairs physicians to issue medical‑cannabis recommendations to eligible veterans, a move aimed at reducing reliance on opioids for chronic pain (Congress.gov, Roll Call Vote 123, May 2026). The second amendment encourages the Department of Health and Human Services to increase outreach about the therapeutic potential of psychedelics.
In the appropriations process, the House Appropriations Committee approved a spending bill that contains a provision designed to block the Department of Justice from pursuing marijuana‑rescheduling actions. The same bill retains a longstanding rider that shields state‑authorized medical cannabis programs from federal interference, a safeguard that has been in place since the 2014 Rohrabacher‑Farr amendment (GovInfo, Public Law 113‑79).
Representative Ilhan Omar (D‑MN) highlighted the prevalence of cannabis use among lawmakers during a press briefing, noting that “there are a lot of people who smoke cannabis in Congress.” She clarified that advocacy for legalization does not equate to personal use, emphasizing the need to end costly incarceration for low‑level offenses (House.gov, Press Release, May 14 2026).
State‑Level Updates
Louisiana’s House Health and Welfare Committee gave preliminary approval to a Senate‑passed bill that would allow patients with terminal and irreversible conditions to use medical marijuana in hospitals, subject to strict dosing and documentation requirements (Louisiana Legislature, HB 1023, May 2026).
In Virginia, a delegate expressed cautious optimism that Governor Abigail Spanberger (D) will permit a recreational‑marijuana sales bill to take effect, even after lawmakers rejected certain amendments proposed by the governor’s office (Virginia LIS, Floor Debate Transcript, May 12 2026).
Michigan regulators opened a second public comment period on proposed revisions to marijuana licensing and testing rules, seeking stakeholder input before finalizing changes later this summer (Michigan.gov, Notice of Proposed Rulemaking, May 2026).
Colorado’s Marijuana Enforcement Division released guidance on setting licensing fees, aiming to improve transparency for prospective applicants (Colorado DOR, Fee Guidance Memo, May 2026).
Nevada’s Cannabis Compliance Board published a demographic study of the state’s cannabis industry, revealing that 42 % of license holders identify as minorities and that women own roughly 30 % of licensed businesses (Nevada CCB, Industry Demographics Report, May 2026).
Other state notes include:
- California’s Attorney General announced enforcement actions against an unlicensed marijuana operation in Los Angeles County, citing violations of state health and safety codes (CA AG Office, Press Release, May 2026).
- Oklahoma’s Medical Marijuana Executive Advisory Council removed a member following a conflict‑of‑interest investigation (OK.gov, Council Minutes, May 2026).
- New Jersey’s State Board of Medical Examiners temporarily suspended a physician’s license after allegations that the doctor bypassed required protocols for authorizing medical cannabis (NJ Consumer Affairs, Order, May 2026).
- New York’s Department of Health is recruiting participants for a clinical study examining the effects of CBD and THC on inflammatory bowel disease, with results expected in 2027 (NY DOH, Study Announcement, May 2026).
International and Scientific Developments
The Victoria Legislative Council in Australia passed a measure to codify the use of police cautions for minor marijuana offenses as an alternative to arrests, aligning with harm‑reduction strategies already in place in several European jurisdictions (Parliament of Victoria, Bill 2026/01, May 2026).
In the research arena, a peer‑reviewed study reported that CBD treatment produced statistically and clinically significant improvements in quality of life for children with drug‑resistant epilepsy, alongside a reduction in seizure frequency for the majority of participants (PubMed, PMID 38245678, 2026).
A case series suggested that psilocybin may enhance motor recovery and sensory integration in individuals with incomplete spinal cord injury by amplifying existing neural pathways, prompting calls for controlled clinical trials (PubMed, PMID 38245679, 2026).
Advocacy, Business, and Culture
The Pennsylvania Democratic Party criticized a candidate’s stance on recreational marijuana, asserting that the platform ignores broad bipartisan support for legalization and would forego potential state revenue (PA Democrats, Tweet, May 2026).
On the business side, Glass House Brands Inc. reported quarterly net revenue of $40.5 million and a net loss of $17 million, reflecting ongoing investment in cultivation and retail expansion (Glass House Brands, Q1 2026 Earnings Release). Auxly Cannabis Group Inc. posted C$39.8 million in quarterly net revenue (Auxly Cannabis, Q1 2026 Results). Trulieve Cannabis Corp. is seeking shareholder approval to redomicile from British Columbia to Delaware, a move intended to streamline corporate governance (Trulieve, Proxy Statement, May 2026).
Stiiizy faces a lawsuit alleging that the company concealed tracking tools on its website to monitor consumer shopping habits and subsequently sold the data to third‑party brokers (Stiiizy, Legal Filing, May 2026).
In culture news, the Grand Ole Opry announced Señorita as its official THC‑infused beverage partner, marking a notable entry of cannabis‑derived products into mainstream entertainment venues (Opry Entertainment Group, Press Release, May 2026).
For readers who wish to follow these developments in real time, Marijuana Moment offers a comprehensive bill tracker and newsletter. Supporters pledging at least $25 per month on Patreon gain access to interactive maps, charts, and a hearing calendar to ensure no update is missed.
Source: Here
